Crossmark

Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark

Crossref DOI link: https://doi.org/10.1186/s13063-020-04714-3

Published Online: 2020-09-17

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Madsen, Anne Marie Rosendahl https://orcid.org/0000-0002-3396-3554
Schaltz-Buchholzer, Frederik

Benfield, Thomas

Bjerregaard-Andersen, Morten

Dalgaard, Lars Skov

Dam, Christine

Ditlev, Sisse Bolm

Faizi, Gulia

Johansen, Isik Somuncu

Kofoed, Poul-Erik

Kristensen, Gitte Schultz

Loekkegaard, Ellen Christine Leth

Mogensen, Christian Backer

Mohamed, Libin

Ostenfeld, Anne

Oedegaard, Emilie Sundhaugen

Soerensen, Marcus Kjaer

Wejse, Christian

Jensen, Aksel Karl Georg

Nielsen, Sebastian

Krause, Tyra Grove

Netea, Mihai G.

Aaby, Peter

Benn, Christine Stabell
Funding

Funding for this research was provided by:

Torben og Alice Frimodts Fond
License Information

Text and Data Mining valid from 2020-09-17

Version of Record valid from 2020-09-17
More Information

Article History

Received: 21 August 2020

Accepted: 27 August 2020

First Online: 17 September 2020

Ethics approval and consent to participate

: The trial has been approved by The Regional Committee on Health Research Ethics for Southern Denmark on April 30, 2020 (reference number: S-20200062C) and by the Danish Medicines Agency on April 27, 2020 (reference number 2020041936).Before participating, all subjects are asked to sign a consent form after receiving oral and written information about the study.We declare that we certify that this trial has received ethical approval from the appropriate ethical committee as described above.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below